StockNews.com Begins Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the medical technology company’s stock.

Other equities analysts have also issued research reports about the stock. Benchmark restated a “speculative buy” rating and issued a $0.40 target price on shares of BIOLASE in a report on Wednesday, October 2nd. Ascendiant Capital Markets dropped their price objective on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd.

BIOLASE Price Performance

Shares of NASDAQ BIOL opened at $0.01 on Wednesday. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94. The company has a 50 day simple moving average of $0.02 and a 200 day simple moving average of $0.07. The firm has a market cap of $183,738.50, a PE ratio of 0.00 and a beta of 0.67.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC lifted its position in BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the quarter. Virtu Financial LLC owned approximately 0.43% of BIOLASE worth $27,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.